Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection

  • Pharmacol Res. 2020 Jul;157:104837. doi: 10.1016/j.phrs.2020.104837.
Roberto Maggio  1 ,  Giovanni U Corsini  2
Affiliations
  • 1. Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy. Electronic address: [email protected].
  • 2. Former Professor of Pharmacology, School of Medicine, University of Pisa, Italy. Electronic address: [email protected].
PMID: 32334052 DOI: 10.1016/j.phrs.2020.104837
Products